On September 10, a delegation led by Sheikh Saud bin Saqr Al Qasimi, member of the Supreme Council of the UAE and Ruler of Ras Al Khaimah, visited Dongguan. During their visit, they attended the China (Dongguan) - UAE (Ras Al Khaimah) Economic and Trade Exchange Symposium hosted by the Dongguan Municipal Bureau of Commerce.
This symposium aims to enhance Dongguan enterprises' understanding of Ras Al Khaimah's business environment and investment policies, foster cooperation and exchanges between Ras Al Khaimah and Dongguan in high-tech industries and manufacturing sectors, and further promote the economic and trade cooperation between the two sides.
EVERON HEALTHCARE had the honor of being invited to participate in this symposium and spoke as one of the two representative companies from Dongguan. At the event, a brief yet impressive presentation was given on EVERON HEALTHCARE "Recombinant Humanized Collagen" project and the company's products.
(At the seminar, Ann Zhang , the Deputy General Manager of EVERON HEALTHCARE, presented on the "Recombinant Humanized Collagen" project )
EVERON HEALTHCARE is a subsidiary under the Jinmeiji Group. As a leading high-tech enterprise in Guangdong Province, Jinmeiji has achieved significant research and development accomplishments across various fields through 29 years of relentless effort. It has established enduring and close partnerships with renowned scientific research institutions and CRO agencies to jointly explore the cutting edge of the biopharmaceutical industry.
EVERON HEALTHCARE is a biopharmaceutical enterprise specializing in synthetic biology, regenerative medical materials, and cosmetic products. It stands as one of the few leading companies in China capable of protein modification and optimization across sequence-structure-function aspects.
EVERON HEALTHCARE is steadfastly committed to pioneering innovation and growth within the biotech sector. Our flagship "Recombinant Humanized Collagen" project has garnered substantial policy backing from the Dongguan Municipal Government. Leveraging the distinctive edge of our "Ultimate Triple Helix," our products deliver an unprecedented experience filled with delightful surprises for users.
EVERON HEALTHCARE, with its exceptional capabilities and innovative products, has garnered widespread attention at the symposium, showcasing the elegance and strength of Dongguan enterprises to the attending guests.
At the symposium, the Ras Al Khaimah delegation demonstrated a strong interest in Dongguan's biopharmaceutical industry. Particularly, they showed great favor for EVERON HEALTHCARE Recombinant Humanized Collagen product.
It is worth mentioning that Ras Al Khaimah boasts a cross-border e-commerce platform and has introduced favorable policies such as the first year of rent-free offices, providing ample space and excellent opportunities for further cooperation between the two parties. On this international exchange platform, EVERON HEALTHCARE actively seeks to communicate and cooperate with various partners to explore more development opportunities. This participation not only serves as an important affirmation of EVERON HEALTHCARE's capabilities but also opens new doors for the company's future growth.
EVERON HEALTHCARE views this symposium as a pivotal opportunity to continually enhance its capabilities. With unwavering confidence, EVERON HEALTHCARE is poised to shine even brighter on the international stage in the days to come, crafting an even more resplendent chapter in its illustrious journey.